Phase II Clinical Study on the Effects of Recombinant Human Interleukin-3 on Thrombocytopenia After Chemotherapy for Advanced Ovarian Cancer
- 期刊名称Journal of Immunotherapy
- 作者Yamamoto, Kaichiro; Yajima, Akira; Terashima, Yoshiteru; Nozawa, Shiro; Taketani, Yuji; Yakushiji, Michiaki; Noda, Kiichiaki
- 卷第22卷
- 期第6期
- 印刷ISSN1524-9557
- 文件大小583.93KB
- 发表时间1999-11
- DOI10.1097/00002371-199911000-00008
- 页码539-545
Immunoprevention approaches for cancer preventionUmar, Asad · Journal for Immunotherapy of Cancer · 2014
Cracking the StoneBajor, David L.; Vonderheide, Robert H. · Journal of Immunotherapy · 2013
Peripheral Neuropathy Associated With IpilimumabThaipisuttikul, Iyavut; Chapman, Paul; Avila, Edward K. · Journal of Immunotherapy · 2015
CD40 Therapy and SurgeryByrne, Katelyn T.; Vonderheide, Robert H. · Journal of Immunotherapy · 2013
Renal Cell CarcinomaAcquavella, Nicolas; Fojo, Tito · Journal of Immunotherapy · 2013
Letter to the editorFadul, Camilo E; Fisher, Jan L; Hampton, Thomas H; Ernstoff, Marc S · Journal for ImmunoTherapy of Cancer · 2014
PembrolizumabKhoja, Leila; Butler, Marcus O.; Kang, S. Peter; Ebbinghaus, Scot; Joshua, Anthony M. · Journal for ImmunoTherapy of Cancer · 2015
Immune monitoring technology primer: immunosequencingKirsch, Ilan · Journal for ImmunoTherapy of Cancer · 2015